P. Sandercock Et Al. , "The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke," LANCET , vol.349, no.9065, pp.1569-1581, 1997
Sandercock, P. Et Al. 1997. The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. LANCET , vol.349, no.9065 , 1569-1581.
Sandercock, P., Collins, R., Counsell, C., Farrell, B., Peto, R., Slattery, J., ... Warlow, C.(1997). The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. LANCET , vol.349, no.9065, 1569-1581.
Sandercock, P Et Al. "The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke," LANCET , vol.349, no.9065, 1569-1581, 1997
Sandercock, P Et Al. "The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke." LANCET , vol.349, no.9065, pp.1569-1581, 1997
Sandercock, P. Et Al. (1997) . "The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke." LANCET , vol.349, no.9065, pp.1569-1581.
@article{article, author={P Sandercock Et Al. }, title={The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke}, journal={LANCET}, year=1997, pages={1569-1581} }